HuGE Literature Finder
Records
1
-
20
| Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. Blood advances 2021 10 6 (2): 637-651. Witte Hanno M, Künstner Axel, Hertel Nadine, Bernd Heinz-Wolfram, Bernard Veronica, Stölting Stephanie, Merz Hartmut, von Bubnoff Nikolas, Busch Hauke, Feller Alfred C, Gebauer Nikl |
| Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Jul JCO2000461. Samur Mehmet Kemal, Aktas Samur Anil, Fulciniti Mariateresa, Szalat Raphael, Han Tessa, Shammas Masood, Richardson Paul, Magrangeas Florence, Minvielle Stephane, Corre Jill, Moreau Philippe, Thakurta Anjan, Anderson Kenneth C, Parmigiani Giovanni, Avet-Loiseau Hervé, Munshi Nikhil |
| BRAF and DIS3 Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 1 26 (10): 2422-2432. Boyle Eileen M, Ashby Cody, Tytarenko Ruslana G, Deshpande Shayu, Wang Hongwei, Wang Yan, Rosenthal Adam, Sawyer Jeffrey, Tian Erming, Flynt Erin, Hoering Antje, Johnson Sarah K, Rutherford Michael W, Wardell Christopher P, Bauer Michael A, Dumontet Charles, Facon Thierry, Thanendrarajan Sharmilan, Schinke Carolina D, Zangari Maurizio, van Rhee Frits, Barlogie Bart, Cairns David, Jackson Graham, Thakurta Anjan, Davies Faith E, Morgan Gareth J, Walker Brian |
| Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 5 38 (21): 2380-2389. Bustoros Mark, Sklavenitis-Pistofidis Romanos, Park Jihye, Redd Robert, Zhitomirsky Benny, Dunford Andrew J, Salem Karma, Tai Yu-Tzu, Anand Shankara, Mouhieddine Tarek H, Chavda Selina J, Boehner Cody, Elagina Liudmila, Neuse Carl Jannes, Cha Justin, Rahmat Mahshid, Taylor-Weiner Amaro, Van Allen Eliezer, Kumar Shaji, Kastritis Efstathis, Leshchiner Ignaty, Morgan Elizabeth A, Laubach Jacob, Casneuf Tineke, Richardson Paul, Munshi Nikhil C, Anderson Kenneth C, Trippa Lorenzo, Aguet François, Stewart Chip, Dimopoulos Meletios-Athanasios, Yong Kwee, Bergsagel P Leif, Manier Salomon, Getz Gad, Ghobrial Irene |
| RAS/RAF mutations in tumor samples and cell-free DNA from plasma and bone marrow aspirates in multiple myeloma patients. Journal of Cancer 2020 4 11 (12): 3543-3550. Li Qian, Huang Helen J, Ma Jing, Wang Yafei, Cao Zeng, Karlin-Neumann George, Janku Filip, Liu Zhiqia |
| Genetic and transcriptional landscape of plasma cells in POEMS syndrome. Leukemia 2019 Jan . Nagao Yuhei, Mimura Naoya, Takeda June, Yoshida Kenichi, Shiozawa Yusuke, Oshima Motohiko, Aoyama Kazumasa, Saraya Atsunori, Koide Shuhei, Rizq Ola, Hasegawa Yoshinori, Shiraishi Yuichi, Chiba Kenichi, Tanaka Hiroko, Nishijima Dai, Isshiki Yusuke, Kayamori Kensuke, Kawajiri-Manako Chika, Oshima-Hasegawa Nagisa, Tsukamoto Shokichi, Mitsukawa Shio, Takeda Yusuke, Ohwada Chikako, Takeuchi Masahiro, Iseki Tohru, Misawa Sonoko, Miyano Satoru, Ohara Osamu, Yokote Koutaro, Sakaida Emiko, Kuwabara Satoshi, Sanada Masashi, Iwama Atsushi, Ogawa Seishi, Nakaseko Chia |
| KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma. Frontiers in oncology 2019 9 1137. Pasca Sergiu, Tomuleasa Ciprian, Teodorescu Patric, Ghiaur Gabriel, Dima Delia, Moisoiu Vlad, Berce Cristian, Stefan Cristina, Ciechanover Aaron, Einsele Herm |
| Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma. Scientific reports 2018 Sep 8 (1): 13522. Wong Kwan Yeung, Yao Qiumei, Yuan Ling-Qing, Li Zhenhai, Ma Edmond Shiu Kwan, Chim Chor Sa |
| Prevalence and Clinicopathologic Significance of BRAF V600E Mutation in Chinese Multiple Myeloma Patients. Clinical lymphoma, myeloma & leukemia 2018 May . Cheung Coty H Y, Cheng Chi Keung, Lau Kin-Mang, Ip Rosalina K L, Chan Nelson C N, Tam Tommy H C, Wong Raymond S M, Raghupathy Radha, Chan Natalie P H, Ng Margaret H |
| Risk Stratification and Targets in Multiple Myeloma: From Genomics to the Bedside. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2018 May (38): 675-680. Perrot Aurore, Corre Jill, Avet-Loiseau Her |
| A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5. Blood cancer journal 2018 3 8 (3): 35. White Brian S, Lanc Irena, O'Neal Julie, Gupta Harshath, Fulton Robert S, Schmidt Heather, Fronick Catrina, Belter Edward A, Fiala Mark, King Justin, Ahmann Greg J, DeRome Mary, Mardis Elaine R, Vij Ravi, DiPersio John F, Levy Joan, Auclair Daniel, Tomasson Michael |
| Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse. Molecular cytogenetics 2018 11 7. Smetana Jan, Oppelt Jan, Štork Martin, Pour Lud?k, Kuglík Pe |
| Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates. Nature communications 2017 May 8 15086. Kis Olena, Kaedbey Rayan, Chow Signy, Danesh Arnavaz, Dowar Mark, Li Tiantian, Li Zhihua, Liu Jessica, Mansour Mark, Masih-Khan Esther, Zhang Tong, Bratman Scott V, Oza Amit M, Kamel-Reid Suzanne, Trudel Suzanne, Pugh Trevor |
| Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation. Oncogenesis 2017 May 6 (5): e337. Xu J, Pfarr N, Endris V, Mai E K, Md Hanafiah N H, Lehners N, Penzel R, Weichert W, Ho A D, Schirmacher P, Goldschmidt H, Andrulis M, Raab M |
| Genomics of Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Mar 35 (9): 963-967. Robiou du Pont Sebastien, Cleynen Alice, Fontan Charlotte, Attal Michel, Munshi Nikhil, Corre Jill, Avet-Loiseau Her |
| Mutational landscape reflects the biological continuum of plasma cell dyscrasias. Blood cancer journal 2017 Feb 7 (2): e537. Rossi A, Voigtlaender M, Janjetovic S, Thiele B, Alawi M, März M, Brandt A, Hansen T, Radloff J, Schön G, Hegenbart U, Schönland S, Langer C, Bokemeyer C, Binder |
| The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma. Oncotarget 2017 Feb . Stein Caleb K, Pawlyn Charlotte, Chavan Shweta, Rasche Leo, Weinhold Niels, Corken Adam, Buros Amy, Sonneveld Pieter, Jackson Graham H, Landgren Ola, Mughal Tariq, He Jie, Barlogie Bart, Leif Bergsagel P, Davies Faith E, Walker Brian A, Morgan Gareth |
| Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation. Oncotarget 2015 Sep 6 (27): 24205-17. Lionetti Marta, Barbieri Marzia, Todoerti Katia, Agnelli Luca, Marzorati Simona, Fabris Sonia, Ciceri Gabriella, Galletti Serena, Milesi Giulia, Manzoni Martina, Mazzoni Mara, Greco Angela, Tonon Giovanni, Musto Pellegrino, Baldini Luca, Neri Antoni |
| [Cytogenetic abnormalities in high-risk multiple myeloma]. Nihon rinsho. Japanese journal of clinical medicine 2015 Jan 73 (1): 28-32. Ishida Tad |
| Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer cell 2014 Jan 25 (1): 91-101. Lohr Jens G, Stojanov Petar, Carter Scott L, Cruz-Gordillo Peter, Lawrence Michael S, Auclair Daniel, Sougnez Carrie, Knoechel Birgit, Gould Joshua, Saksena Gordon, Cibulskis Kristian, McKenna Aaron, Chapman Michael A, Straussman Ravid, Levy Joan, Perkins Louise M, Keats Jonathan J, Schumacher Steven E, Rosenberg Mara, , Getz Gad, Golub Todd |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 30, 2023
- Content source: